Eli Lilly and Company (NYSE:LLY) – Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation

December 02, 2013 at 10:47 AM EST

[PR Newswire] – RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 2, 2013 /PRNewswire/ — Boehringer Ingelheim and Eli Lilly and Company (LLY) today announced the launch of the largest multinational survey to investigate early conversations . . . → Read More: Eli Lilly and Company (NYSE:LLY) – Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation Similar posts: Company Update – Bristol-Myers Squibb Company (NYSE:BMY) – Xigduo™ (dapagliflozin and metformin hydrochloride) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes Stock Update: Merck & Co. Inc. (NYSE:MRK) – Merck announces CHMP Positive Opinion to Update Erbitux Metastatic Colorectal Cancer Labeling to Patients with RAS Wild-type Tumors German ZEW survey on tap

Eli Lilly and Company (NYSE:LLY) [PR Newswire] – RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 2, 2013 /PRNewswire/ — Boehringer Ingelheim and Eli Lilly and Company (LLY) today announced the launch of the largest multinational survey to investigate early conversations between physicians and people living with type 2 diabetes at time of diagnosis and at time of treatment modification. The survey was developed in partnership with the International Diabetes Federation (IDF) and will include more than 10,000 people … [visit site to read more]